메뉴 건너뛰기




Volumn 52, Issue 6, 2005, Pages 1100-1101

Thalidomide in mycosis fungoides [2]

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

EID: 19544391055     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.01.104     Document Type: Article
Times cited : (10)

References (12)
  • 1
    • 0029548149 scopus 로고
    • Immunomodulation by thalidomide: Systematic review of the literature and of unpublished observations
    • K. Zwingenberger, and S. Wnendt Immunomodulation by thalidomide: systematic review of the literature and of unpublished observations J Inflamm 46 1995 177 211
    • (1995) J Inflamm , vol.46 , pp. 177-211
    • Zwingenberger, K.1    Wnendt, S.2
  • 2
    • 0242574324 scopus 로고    scopus 로고
    • Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells
    • L. Deng, W. Ding, and R.D. Granstein Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells J Invest Dermatol 121 2003 1060 1065
    • (2003) J Invest Dermatol , vol.121 , pp. 1060-1065
    • Deng, L.1    Ding, W.2    Granstein, R.D.3
  • 3
    • 0642276742 scopus 로고    scopus 로고
    • Treatment of plasma cell dyscrasias with thalidomide and its derivatives
    • M.A. Dimopoulos, A. Anagnostopoulos, and D. Weber Treatment of plasma cell dyscrasias with thalidomide and its derivatives J Clin Oncol 21 2003 4444 4454
    • (2003) J Clin Oncol , vol.21 , pp. 4444-4454
    • Dimopoulos, M.A.1    Anagnostopoulos, A.2    Weber, D.3
  • 4
    • 0038663022 scopus 로고    scopus 로고
    • Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease
    • M.E. Flowers, and P.J. Martin Evaluation of thalidomide for treatment or prevention of chronic graft-versus-host disease Leuk Lymphoma 44 2003 1141 1146
    • (2003) Leuk Lymphoma , vol.44 , pp. 1141-1146
    • Flowers, M.E.1    Martin, P.J.2
  • 5
    • 0036196210 scopus 로고    scopus 로고
    • Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement
    • S.J. Oliver, T. Kikuchi, J.G. Krueger, and G. Kaplan Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement Clin Immunol 102 2002 225 236
    • (2002) Clin Immunol , vol.102 , pp. 225-236
    • Oliver, S.J.1    Kikuchi, T.2    Krueger, J.G.3    Kaplan, G.4
  • 6
    • 0028928143 scopus 로고
    • The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures
    • S.M. McHugh, I.R. Rifkin, and J. Deighton The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures Clin Exp Immunol 99 1995 160 167
    • (1995) Clin Exp Immunol , vol.99 , pp. 160-167
    • McHugh, S.M.1    Rifkin, I.R.2    Deighton, J.3
  • 7
    • 0032100486 scopus 로고    scopus 로고
    • Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset
    • P.A. Haslett, L.G. Corral, M. Albert, and G. Kaplan Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset J Exp Med 187 1998 1885 1892
    • (1998) J Exp Med , vol.187 , pp. 1885-1892
    • Haslett, P.A.1    Corral, L.G.2    Albert, M.3    Kaplan, G.4
  • 8
    • 2342531057 scopus 로고    scopus 로고
    • The pathogenesis of mycosis fungoides
    • M. Girardi, P.W. Heald, and L.D. Wilson The pathogenesis of mycosis fungoides N Engl J Med 350 2004 1978 1988
    • (2004) N Engl J Med , vol.350 , pp. 1978-1988
    • Girardi, M.1    Heald, P.W.2    Wilson, L.D.3
  • 9
    • 3142783760 scopus 로고    scopus 로고
    • Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: Efficacy and risk of neuropathy
    • T. Maurer, A. Poncelet, and T. Berger Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects: efficacy and risk of neuropathy Arch Dermatol 140 2004 845 849
    • (2004) Arch Dermatol , vol.140 , pp. 845-849
    • Maurer, T.1    Poncelet, A.2    Berger, T.3
  • 10
    • 0036446745 scopus 로고    scopus 로고
    • Incidence and risk factors for thalidomide neuropathy: A prospective study of 135 dermatologic patients
    • S. Bastuji-Garin, S. Ochonisky, and P. Bouche Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients J Invest Dermatol 119 2002 1020 1026
    • (2002) J Invest Dermatol , vol.119 , pp. 1020-1026
    • Bastuji-Garin, S.1    Ochonisky, S.2    Bouche, P.3
  • 11
    • 0842310884 scopus 로고    scopus 로고
    • Treatment of cutaneous sarcoidosis with thalidomide
    • Y. Nguyen, A. Dupuy, and F. Cordoliani Treatment of cutaneous sarcoidosis with thalidomide J Am Acad Dermatol 50 2004 235 241
    • (2004) J Am Acad Dermatol , vol.50 , pp. 235-241
    • Nguyen, Y.1    Dupuy, A.2    Cordoliani, F.3
  • 12
    • 0344305652 scopus 로고    scopus 로고
    • Low-dose thalidomide treatment for advanced hepatocellular carcinoma
    • C. Hsu, C.N. Chen, and L.T. Chen Low-dose thalidomide treatment for advanced hepatocellular carcinoma Oncology 65 2003 242 249
    • (2003) Oncology , vol.65 , pp. 242-249
    • Hsu, C.1    Chen, C.N.2    Chen, L.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.